HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Criteria for early identification of aceruloplasminemia.

Abstract
A 52-year-old Japanese woman being treated for type 1 diabetes showed forgetfulness and microcytic anemia with a high serum ferritin concentration. Serum and brain radiological examinations revealed aceruloplasminemia, which was confirmed by genetic testing. Aceruloplasminemia is characterized by the triad of retinal degeneration, diabetes mellitus, and adult-onset disorder of the extrapyramidal system. Though physicians should treat such patients earlier, it is difficult to diagnose the disease before the presentation of neurological symptoms. Despite the presence of microcytic anemia, aceruloplasminemia patients usually have a high serum ferritin concentration due to the complete absence of ceruloplasmin ferroxidase activity. Thus, physicians should consider aceruloplasminemia when diabetic patients present with microcytic anemia and a high serum ferritin concentration.
AuthorsMasaro Ogimoto, Keizo Anzai, Hiromasa Takenoshita, Kazuhiko Kogawa, Yuko Akehi, Ryoko Yoshida, Makiko Nakano, Kunihiro Yoshida, Junko Ono
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 50 Issue 13 Pg. 1415-8 ( 2011) ISSN: 1349-7235 [Electronic] Japan
PMID21720062 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ceruloplasmin
  • Sialyltransferases
  • polysialyltransferase-1, human
Topics
  • Ceruloplasmin (deficiency, genetics)
  • Diabetes Mellitus, Type 1 (complications, diagnosis, genetics)
  • Early Diagnosis
  • Female
  • Humans
  • Iron Metabolism Disorders (complications, diagnosis, genetics)
  • Middle Aged
  • Neurodegenerative Diseases (complications, diagnosis, genetics)
  • Pedigree
  • Sialyltransferases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: